Evidence map›Paper›PMID 32750572›Full record

Trial reportPsychiatry research2020

Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.

Bernadette A Cullen, Katrina Rodriguez, William W Eaton, Ramin Mojtabai, Tara Von Mach, Michele L Ybarra

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychiatry research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 5 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 5 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bernadette A CullenDepartment of Psychiatry and Behavioral Sciences, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; Department of Mental Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: bcullen@jhmi.edu.
Katrina RodriguezDepartment of Mental Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
William W EatonDepartment of Mental Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ramin MojtabaiDepartment of Psychiatry and Behavioral Sciences, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; Department of Mental Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Tara Von MachAnn & Robert H. Lurie Children's Hospital of Chicago, USA.
Michele L YbarraDepartment of Mental Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Center for Innovative Public Health Research, San Clemente, California, USA.
Johns Hopkins University · USLurie Children's Hospital · US

Funding

PSYCHIATRIC EPIDEMIOLOGY TRAINING PROGRAMT32MH014592 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HEATHER E VOLK, Peter P. Zandi · 1985 to 2026
$8.5M
Texting for Relapse Prevention: Improving outcomes for people with schizophreniaR34MH108781 · NIMH · CENTER FOR INNOVATIVE PUBLIC HEALTH RESEARCH · PI GOGGINS, BERNADETTE, YBARRA, MICHELE L. · 2016 to 2018
$731k
NIMH NIH HHS R34 MH108781NIMH NIH HHS T32 MH014592
6 · The paper itself

Abstract

This 6 month randomized control trial investigated whether a novel text-messaging program impacted targeted clinical outcomes in patients with schizophrenia and schizoaffective disorder (SAD). Forty patients were enrolled and completed baseline, 3-month and 6-month assessments. The intervention group received daily symptom check-in text messages, plus, a medication reminder or, inspirational quote text. The control group had treatment as usual. At 6 months the Positive and Negative Syndrome Scale mean positive score was significantly lower and injectable medication compliance was significantly higher in the intervention group. Recovery scores were significantly higher at 3 months. Results suggest that this program may benefit individuals with schizophrenia/SAD who use text messaging. Further investigation in a larger sample appears warranted.

Indexed as

Text MessagingAdultFemaleFollow-Up StudiesHumansMaleMedication AdherenceMiddle AgedPilot ProjectsPsychotic DisordersSchizophreniaSchizophrenic PsychologySecondary Prevention

Identifiers

PMID32750572
PMCPMC7530047
OpenAlexW3045756053

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.